ASBEL is a target of Wnt/β-catenin signaling which is correlated with tumorigenesis, metastasis, cancer stemness, and poor prognosis in TNBC patients, and can be inhibited by antago3. This evidence concerns the gene BTG3-AS1 and cancer.